{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:29:01Z","timestamp":1790753341951,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Romani people have a high prevalence of kidney failure. This study examined a Romani cohort for pathogenic variants in the <jats:italic>COL4A3, COL4A4<\/jats:italic>, and <jats:italic>COL4A5<\/jats:italic> genes that are affected in Alport syndrome (AS), a common cause of genetic kidney disease, characterized by hematuria, proteinuria, end-stage kidney failure, hearing loss, and eye anomalies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The study included 57 Romani from different families with clinical features that suggested AS who underwent next-generation sequencing (NGS) of the <jats:italic>COL4A3, COL4A4, and COL4A5<\/jats:italic> genes, and 83 family members.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 27 Romani (19%) had autosomal recessive AS caused by a homozygous pathogenic c.1598G&amp;gt;A, p.Gly533Asp variant in <jats:italic>COL4A4<\/jats:italic> (<jats:italic>n<\/jats:italic> = 20) or a homozygous c.415G&amp;gt;C, p.Gly139Arg variant in <jats:italic>COL4A3<\/jats:italic> (<jats:italic>n<\/jats:italic> = 7). For p.Gly533Asp, 12 (80%) had macroscopic hematuria, 12 (63%) developed end-stage kidney failure at a median age of 22 years, and 13 (67%) had hearing loss. For p.Gly139Arg, none had macroscopic hematuria (<jats:italic>p<\/jats:italic> = 0.023), three (50%) had end-stage kidney failure by a median age of 42 years (<jats:italic>p<\/jats:italic> = 0.653), and five (83%) had hearing loss (<jats:italic>p<\/jats:italic> = 0.367). The p.Gly533Asp variant was associated with a more severe phenotype than p.Gly139Arg, with an earlier age at end-stage kidney failure and more macroscopic hematuria. Microscopic hematuria was very common in heterozygotes with both p.Gly533Asp (91%) and p.Gly139Arg (92%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These two founder variants contribute to the high prevalence of kidney failure in Czech Romani. The estimated population frequency of autosomal recessive AS from these variants and consanguinity by descent is at least 1:11,000 in Czech Romani. This corresponds to a population frequency of autosomal dominant AS from these two variants alone of 1%. Romani with persistent hematuria should be offered genetic testing.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1096869","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T07:28:08Z","timestamp":1675841288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A founder COL4A4 pathogenic variant resulting in autosomal recessive Alport syndrome accounts for most genetic kidney failure in Romani people"],"prefix":"10.3389","volume":"10","author":[{"given":"Pavlina","family":"Plevova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Indrakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Savige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kuhnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Tvrda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dita","family":"Cerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarka","family":"Hilscherova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kudrejova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Polendova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Jaklova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Langova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Jahnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Lastuvkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Dusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Vlckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Solarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Kreckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kantorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Soukalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rastislav","family":"Slavkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Zapletalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Tichy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Thomasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen.","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group.","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cge.13077","article-title":"Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.","volume":"92","author":"Papazachariou","year":"2017","journal-title":"Clin Genet."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.865034","article-title":"Genotype-phenotype correlations for pathogenic COL4A3\u2013COL4A5 variants in X-linked, autosomal recessive, and autosomal dominant Alport syndrome.","volume":"9","author":"Savige","year":"2022","journal-title":"Front Med."},{"key":"B6","first-page":"569","article-title":"[Alport\u015b syndrome in Eastern Slovakia.] (Slovak).","volume":"41","author":"Kluka","year":"1986","journal-title":"CS Pediat."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00038-014-0609-z","article-title":"Kidney diseases in Roma and non-Roma children from eastern Slovakia: are Roma children more at risk?.","volume":"59","author":"Kolvek","year":"2014","journal-title":"Int J Public Health."},{"key":"B8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/1355785032000136434","article-title":"Roma health issues: a review of the literature and discussion.","volume":"8","author":"Zeman","year":"2003","journal-title":"Ethn Health."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-2-5","article-title":"Genetic studies of the Roma (gypsies): a review.","volume":"2","author":"Kalaydjieva","year":"2001","journal-title":"BMC Med Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1046\/j.1523-1755.63.s83.24.x","article-title":"End-stage renal disease in India and Pakistan: burden of disease and management issues.","volume":"83","author":"Sakhuja","year":"2003","journal-title":"Kidney Int Suppl."},{"key":"B11","doi-asserted-by":"publisher","first-page":"c197","DOI":"10.1159\/000199460","article-title":"Chronic kidney disease in India: challenges and solutions.","volume":"111","author":"Agarwal","year":"2009","journal-title":"Nephron Clin Pract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1046\/j.1523-1755.63.s83.29.x","article-title":"Preventing renal disease: the ethnic challenge in the United Kingdom.","volume":"83","author":"Lightstone","year":"2003","journal-title":"Kidney Int Suppl."},{"key":"B13","first-page":"1157","article-title":"A mutation causing Alport syndrome with tardive hearing loss is common in the western United States.","volume":"58","author":"Barker","year":"1996","journal-title":"Am J Hum Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s004390050429","article-title":"Common ancestry of three Ashkenazi-American families with Alport syndrome and COL4A5 R1677Q.","volume":"99","author":"Barker","year":"1997","journal-title":"Hum Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cge.12247","article-title":"A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population.","volume":"86","author":"Webb","year":"2014","journal-title":"Clin Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.kint.2020.10.040","article-title":"Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central\/East Europe and causes kidney failure in midlife.","volume":"99","author":"Zurowska","year":"2021","journal-title":"Kidney Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Genomics England research consortiumprevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome.","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-014-0154-7","article-title":"Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic.","volume":"14","author":"Stehlikova","year":"2014","journal-title":"BMC Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177685","article-title":"Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","article-title":"LOVD v.2.0: the next generation in gene variant databases.","volume":"32","author":"Fokkema","year":"2011","journal-title":"Hum Mutat."},{"key":"B23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ejhg.2013.77","article-title":"Combined array CGH plus SNP genome analyses in a single assay for optimized clinical testing.","volume":"22","author":"Wiszniewska","year":"2014","journal-title":"Eur J Hum Genet."},{"key":"B24","year":"","journal-title":"Czech radio [Romani in Czech Republic] (Czech) (1997\u20132023)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00038-012-0365-x","article-title":"End-stage renal disease among Roma and non-Roma: ROMA are at risk.","volume":"57","author":"Kolvek","year":"2012","journal-title":"Int J Public Health."},{"key":"B26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome.","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/humu.9065","article-title":"Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.","volume":"20","author":"Dagher","year":"2002","journal-title":"Hum Mutat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00467-014-2797-4","article-title":"Natural history of genetically proven autosomal recessive Alport syndrome.","volume":"29","author":"Oka","year":"2014","journal-title":"Pediatr Nephrol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020178","article-title":"Features of autosomal recessive Alport syndrome: a systematic review.","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2215\/CJN.01000116","article-title":"Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome.","volume":"11","author":"Kamiyoshi","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","article-title":"Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: a systematic review.","volume":"13","author":"Matthaiou","year":"2020","journal-title":"Clin Kidney J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/j.ajkd.2021.02.326","article-title":"Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study.","volume":"78","author":"Furlano","year":"2021","journal-title":"Am J Kidney Dis."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06525-9","article-title":"Genotype-phenotype correlations for COL4A3-COL4A5 variants that result in Gly substitutions in Alport syndrome.","volume":"12","author":"Gibson","year":"2022","journal-title":"Sci Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/gte.2007.0048","article-title":"Carrier rates of the ancestral Indian W24X mutation in GJB2 in the general gypsy population and individual subisolates.","volume":"11","author":"Bouwer","year":"2007","journal-title":"Genet Test."},{"key":"B35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1399-0004.2011.01817.x","article-title":"DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population.","volume":"82","author":"Safka Brozkova","year":"2012","journal-title":"Clin Genet."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01508-3","article-title":"Variant c.2158-2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant.","volume":"15","author":"Safka Brozkova","year":"2020","journal-title":"Orphanet J Rare Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1096869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T12:37:21Z","timestamp":1675946241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1096869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":36,"alternative-id":["10.3389\/fmed.2023.1096869"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1096869","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"article-number":"1096869"}}